{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:45:05Z","timestamp":1792071905378,"version":"4.4.0"},"reference-count":42,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:p>Studies of individuals at risk for developing type 1 diabetes (T1D) have demonstrated that the disease is a continuum that progresses sequentially through distinct identifiable stages before the onset of symptoms. Screening for islet antibodies (IAbs) in at-risk children for T1D (first-degree relatives or those with human leukocyte antigen genetic risk) and in the general population is becoming increasingly common in some countries. The main aim of the T1D screening program is to reduce rates of diabetic ketoacidosis (DKA) at diagnosis and to participate in research protocols that receive T1D-modifying therapies to delay clinical onset. These advantages are generally balanced with the psychological symptoms (such as anxiety and depression) that this information could produce in healthy children-adolescents and their parents, and the costs of the screening. Optimal ages for performing IAb screening in the general population have been established by cohort analyses in several studies. Primary care physicians can be responsible for family enrollment and capillary blood sampling in the general population. For follow-up of individuals who screen positive for IAbs, both age and the number of IAbs detected influence how frequently and intensively monitoring is recommended, as well as whether referral to a specialist care center is advised. Measures considered for monitoring include IAbs, hemoglobin A1c, random blood glucose, oral glucose tolerance test (OGTT), and continuous glucose monitoring (CGM). This article describes how such evidence has been implemented in Italy, offering practical insights into integrating screening into routine pediatric care.<\/jats:p>","DOI":"10.1542\/peds.2025-075728","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:03:16Z","timestamp":1778803396000},"source":"Crossref","is-referenced-by-count":1,"title":["Screening Programs for Type 1 Diabetes in Youth: Evidence for Clinical Practice"],"prefix":"10.1542","volume":"157","author":[{"given":"Roberto","family":"Franceschi","sequence":"first","affiliation":[{"name":"1CISMed - Centro Interdipartimentale di Scienze Mediche, University of Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza","family":"Mozzillo","sequence":"additional","affiliation":[{"name":"2Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marigliano","sequence":"additional","affiliation":[{"name":"3Department of Surgery, Dentistry, Pediatrics and Gynecology, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Maltoni","sequence":"additional","affiliation":[{"name":"4Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Maddaloni","sequence":"additional","affiliation":[{"name":"5Department of Experimental Medicine, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Amendolara","sequence":"additional","affiliation":[{"name":"5Department of Experimental Medicine, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bernardini","sequence":"additional","affiliation":[{"name":"4Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"},{"name":"6University of Bologna UNIBO, Department of Medical and Surgical Sciences DIMEC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bonfanti","sequence":"additional","affiliation":[{"name":"7Department of Pediatrics, Diabetes Research Institute, IRCCS San Raffaele, Milano, Italy"},{"name":"8Universit\u00e0 Vita Salute San Raffaele, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ciambrelli","sequence":"additional","affiliation":[{"name":"4Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Candia","sequence":"additional","affiliation":[{"name":"2Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Fedi","sequence":"additional","affiliation":[{"name":"2Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fierro","sequence":"additional","affiliation":[{"name":"2Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Iafusco","sequence":"additional","affiliation":[{"name":"9Department of Woman, Child and General and Specialistic Surgery, Regional Center of Pediatric Diabetes, University of Campania \u201cL. Vanvitelli,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Iannilli","sequence":"additional","affiliation":[{"name":"10Department of Women\u2019s and Children\u2019s Health, Azienda Ospedaliero-Universitaria delle Marche, \u201cG. Salesi Hospital,\u201d Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Leonardi","sequence":"additional","affiliation":[{"name":"1CISMed - Centro Interdipartimentale di Scienze Mediche, University of Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Maffeis","sequence":"additional","affiliation":[{"name":"3Department of Surgery, Dentistry, Pediatrics and Gynecology, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Maines","sequence":"additional","affiliation":[{"name":"1CISMed - Centro Interdipartimentale di Scienze Mediche, University of Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pertile","sequence":"additional","affiliation":[{"name":"11Department of Clinical and Evaluative Epidemiology, APSS, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Piona","sequence":"additional","affiliation":[{"name":"3Department of Surgery, Dentistry, Pediatrics and Gynecology, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Rabbone","sequence":"additional","affiliation":[{"name":"12Department of Health Sciences, University of Piemonte Orientale, Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Santarelli","sequence":"additional","affiliation":[{"name":"10Department of Women\u2019s and Children\u2019s Health, Azienda Ospedaliero-Universitaria delle Marche, \u201cG. Salesi Hospital,\u201d Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ripoli","sequence":"additional","affiliation":[{"name":"13Pediatric Diabetology Unit, Department of Pediatrics, ASL 8 Cagliari, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Scozzarella","sequence":"additional","affiliation":[{"name":"4Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Tiberi","sequence":"additional","affiliation":[{"name":"10Department of Women\u2019s and Children\u2019s Health, Azienda Ospedaliero-Universitaria delle Marche, \u201cG. Salesi Hospital,\u201d Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[{"name":"5Department of Experimental Medicine, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Cherubini","sequence":"additional","affiliation":[{"name":"10Department of Women\u2019s and Children\u2019s Health, Azienda Ospedaliero-Universitaria delle Marche, \u201cG. Salesi Hospital,\u201d Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"8","key":"2026101508513700800_r1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/pedi.13454","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents","volume":"23","author":"Libman","year":"2022","journal-title":"Pediatr Diabetes."},{"issue":"3","key":"2026101508513700800_r2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41574-024-01045-0","article-title":"Looking back at the TEDDY study: lessons and future directions","volume":"21","author":"Lernmark","year":"2025","journal-title":"Nat Rev Endocrinol."},{"issue":"4","key":"2026101508513700800_r3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MED.0000000000000173","article-title":"General population screening for type 1 diabetes: has its time come?","volume":"22","author":"Insel","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"9","key":"2026101508513700800_r4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00125-024-06205-5","article-title":"Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes","volume":"67","author":"Phillip","year":"2024","journal-title":"Diabetologia."},{"key":"2026101508513700800_r5","article-title":"Consensus guidance for monitoring individuals with islet autoantibody\u2013positive pre-stage 3 type 1 diabetes","volume-title":"Diabetes Care.","author":"Phillip","year":"2024"},{"issue":"Supplement_1","key":"2026101508513700800_r6","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"American Diabetes Association Professional Practice Committee; 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142024","volume":"47","author":"ADA 2024","year":"2024","journal-title":"Diabetes Care."},{"issue":"10","key":"2026101508513700800_r7","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1111\/dom.15779","article-title":"Follow-up and monitoring programme in children identified in early-stage type 1 diabetes during screening in the general population of Italy","volume":"26","author":"Cherubini","year":"2024","journal-title":"Diabetes Obes Metab."},{"issue":"12","key":"2026101508513700800_r8","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1210\/clinem\/dgad328","article-title":"Screening and prevention of type 1 diabetes: where are we?","volume":"108","author":"Simmons","year":"2023","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2026101508513700800_r9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1159\/000543035","article-title":"ISPAD Clinical Practice Consensus Guidelines 2024: screening, staging, and strategies to preserve beta-cell function in children and adolescents with type 1 diabetes","volume":"97","author":"Haller","year":"2024","journal-title":"Horm Res Paediatr."},{"issue":"1","key":"2026101508513700800_r10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13052-023-01438-3","article-title":"Autoantibody test for type 1 diabetes in children: are there reasons to implement a screening program in the general population? A statement endorsed by the Italian Society for Paediatric Endocrinology and Diabetes (SIEDP-ISPED) and the Italian Society of Paediatrics (SIP)","volume":"49","author":"Cherubini","year":"2023","journal-title":"Ital J Pediatr."},{"issue":"7","key":"2026101508513700800_r11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jcjd.2024.07.002","article-title":"Prognostic implications of diabetic ketoacidosis in adults on long-term mortality and diabetes-related complications","volume":"48","author":"Budhram","year":"2024","journal-title":"Can J Diabetes."},{"issue":"7","key":"2026101508513700800_r12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med."},{"issue":"18","key":"2026101508513700800_r13","doi-asserted-by":"crossref","first-page":"e177492","DOI":"10.1172\/JCI177492","article-title":"Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes","volume":"134","author":"Lled\u00f3-Delgado","year":"2024","journal-title":"J Clin Invest."},{"issue":"3","key":"2026101508513700800_r14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2337\/dc25-1021","article-title":"Generalizability of progression risk in the TN-10 trial to a European population with or without a first-degree relative with type 1 diabetes","volume":"49","author":"Koeger","year":"2025","journal-title":"Diabetes Care."},{"issue":"583","key":"2026101508513700800_r15","doi-asserted-by":"crossref","first-page":"eabc8980","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci Transl Med."},{"issue":"2","key":"2026101508513700800_r16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00125-025-06586-1","article-title":"Safety and pharmacokinetics of teplizumab in children less than 8\u00a0years of age with stage 2 type 1 diabetes","volume":"69","author":"Gitelman","year":"2026","journal-title":"Diabetologia."},{"issue":"5","key":"2026101508513700800_r17","first-page":"597","article-title":"Pediatric Endocrine Society Statement on considerations for use of teplizumab (Tzield\u2122) in clinical practice","volume":"98","author":"Tonyushkina","year":"2025","journal-title":"Horm Res Paediatr."},{"issue":"5","key":"2026101508513700800_r18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/dc22-2200","article-title":"Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial","volume":"46","author":"Russell","year":"2023","journal-title":"Diabetes Care."},{"issue":"9","key":"2026101508513700800_r19","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2337\/dc24-0573","article-title":"Oral insulin delay of stage 3 type 1 diabetes revisited in HLA DR4-DQ8 participants in the TrialNet Oral Insulin Prevention Trial (TN07)","volume":"47","author":"Zhao","year":"2024","journal-title":"Diabetes Care."},{"issue":"23","key":"2026101508513700800_r20","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2306691","article-title":"Baricitinib and \u03b2-cell function in patients with new-onset type 1 diabetes","volume":"389","author":"Waibel","year":"2023","journal-title":"N Engl J Med."},{"issue":"5","key":"2026101508513700800_r21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/pedi.13024","article-title":"Parental anxiety after 5\u2009years of participation in a longitudinal study of children at high risk of type 1 diabetes","volume":"21","author":"Melin","year":"2020","journal-title":"Pediatr Diabetes."},{"issue":"12","key":"2026101508513700800_r22","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc23-0350","article-title":"Anxiety and risk perception in parents of children identified by population screening as high risk for type 1 diabetes","volume":"46","author":"O\u2019Donnell","year":"2023","journal-title":"Diabetes Care."},{"issue":"4","key":"2026101508513700800_r23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2337\/dc21-1648","article-title":"Costs of public health screening of children for presymptomatic type 1 diabetes in Bavaria, Germany","volume":"45","author":"Karl","year":"2022","journal-title":"Diabetes Care."},{"issue":"7","key":"2026101508513700800_r24","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dc19-2003","article-title":"Cost and cost-effectiveness of large-scale screening for type 1 diabetes in Colorado","volume":"43","author":"McQueen","year":"2020","journal-title":"Diabetes Care."},{"issue":"9","key":"2026101508513700800_r25","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2337\/dc11-0560","article-title":"Development of autoantibodies in the TrialNet Natural History Study","volume":"34","author":"Vehik","year":"2011","journal-title":"Diabetes Care."},{"issue":"Suppl 6","key":"2026101508513700800_r26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/dom.16522","article-title":"Health economic considerations of screening for early type 1 diabetes","volume":"27","author":"Rewers","year":"2025","journal-title":"Diabetes Obes Metab."},{"issue":"10","key":"2026101508513700800_r27","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2337\/dc20-2122","article-title":"An age-related exponential decline in the risk of multiple islet autoantibody seroconversion during childhood","volume":"44","author":"Bonifacio","year":"2021","journal-title":"Diabetes Care."},{"issue":"8","key":"2026101508513700800_r28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S2213-8587(22)00141-3","article-title":"Two-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort study","volume":"10","author":"Ghalwash","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2026101508513700800_r29","doi-asserted-by":"crossref","first-page":"1386513","DOI":"10.3389\/fped.2024.1386513","article-title":"Home capillary sampling and screening for type 1 diabetes, celiac disease, and autoimmune thyroid disease in a Swedish general pediatric population: the TRIAD study","volume":"12","author":"Naredi Scherman","year":"2024","journal-title":"Front Pediatr."},{"issue":"7","key":"2026101508513700800_r30","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/pedi.12902","article-title":"Screening children for type 1 diabetes-associated antibodies at community health fairs","volume":"20","author":"Simmons","year":"2019","journal-title":"Pediatr Diabetes."},{"issue":"8","key":"2026101508513700800_r31","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1210\/clinem\/dgaf194","article-title":"Establishing screening programs for presymptomatic type 1 diabetes: practical guidance for diabetes care providers","volume":"110","author":"Leichter","year":"2025","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2026101508513700800_r32","doi-asserted-by":"crossref","first-page":"e70071","DOI":"10.1111\/dme.70071","article-title":"Establishing the performance and acceptability of dried blood spot sampling to screen for islet-specific autoantibodies","volume":"42","author":"Faustini","year":"2025","journal-title":"Diabet Med."},{"issue":"12","key":"2026101508513700800_r33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/dia.2015.0133","article-title":"Use of dried capillary blood sampling for islet autoantibody screening in relatives: a feasibility study","volume":"17","author":"Bingley","year":"2015","journal-title":"Diabetes Technol Ther."},{"issue":"2","key":"2026101508513700800_r34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/dia.2023.0345","article-title":"Feasibility and validity of in-home self-collected capillary blood spot screening for type 1 diabetes risk","volume":"26","author":"Sing","year":"2024","journal-title":"Diabetes Technol Ther."},{"issue":"1","key":"2026101508513700800_r35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/dom.16002","article-title":"Development and validation of a novel method for evaluation of multiple islet autoantibodies in dried blood spot using dissociation-enhanced lanthanide fluorescent immunoassays technology, specific and suitable for paediatric screening programmes","volume":"27","author":"Dufrusine","year":"2025","journal-title":"Diabetes Obes Metab."},{"issue":"2","key":"2026101508513700800_r36","doi-asserted-by":"crossref","first-page":"e3777","DOI":"10.1002\/dmrr.3777","article-title":"Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes","volume":"40","author":"Hendriks","year":"2024","journal-title":"Diabetes Metab Res Rev."},{"issue":"4","key":"2026101508513700800_r37","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s00125-020-05365-4","article-title":"Index60 as an additional diagnostic criterion for type 1 diabetes","volume":"64","author":"Redondo","year":"2021","journal-title":"Diabetologia."},{"issue":"6","key":"2026101508513700800_r38","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/dom.13982","article-title":"Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals","volume":"22","author":"Ismail","year":"2020","journal-title":"Diabetes Obes Metab."},{"issue":"1","key":"2026101508513700800_r39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/clinem\/dgad472","article-title":"OGTT metrics surpass continuous glucose monitoring data for T1D prediction in multiple-autoantibody\u2013positive individuals","volume":"109","author":"Ylescupidez","year":"2023","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2026101508513700800_r40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2337\/dc24-2376","article-title":"Repeated OGTT versus continuous glucose monitoring for predicting development of stage 3 type 1 diabetes: a longitudinal analysis","volume":"48","author":"Desouter","year":"2025","journal-title":"Diabetes Care."},{"issue":"2","key":"2026101508513700800_r41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2337\/dc21-0602","article-title":"CGM Metrics predict imminent progression to type 1 diabetes: Autoimmunity Screening for Kids (ASK) Study","volume":"45","author":"Steck","year":"2022","journal-title":"Diabetes Care."},{"issue":"3","key":"2026101508513700800_r42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc22-1297","article-title":"CGM metrics identify dysglycemic states in participants from the TrialNet Pathway to Prevention Study","volume":"46","author":"Wilson","year":"2023","journal-title":"Diabetes Care."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-075728\/1932072\/pediatrics.2025075728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-075728\/1932072\/pediatrics.2025075728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:51:47Z","timestamp":1792068707000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/157\/6\/e2025075728\/207530\/Screening-Programs-for-Type-1-Diabetes-in-Youth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,15]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2025-075728","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"e2025075728"}}